IP posts Q4 net loss $318M on $533M Ilim impairment; adjusted EPS $0.87, up 43% YoY

INTERNATIONAL PAPER CO /NEW/

2022-FY EPS reported $4.10 revenue$21,161,000,000

Full-year 2022 revenue $21.16B (+9% YoY); adjusted operating earnings $1.17B (+24%).
Q4 adjusted operating earnings $309M ($0.87/diluted share) vs $235M ($0.61) in Q4 2021.
Q4 net loss ($318M) includes $533M non-cash Ilim impairment; agreement to sell Ilim stake announced.
Industrial Packaging op profit $416M in Q4, up from $369M Q3; Global Cellulose Fibers $35M, down from $95M.
Returned $1.93B to shareholders in 2022 via buybacks ($1.26B) and dividends ($673M).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

INTERNATIONAL PAPER CO /NEW/ reported Full-Year 2022 results: net income $1.5 billion, EPS $4.10 per diluted share.

Period: Full-Year 2022
Net income: $1.5 billion
EPS: $4.10 per diluted share
Result: reported results

Exact text from the filing

Full-year 2022 net earnings (loss) attributable to International Paper of $1.5 billion ($4.10 per diluted share)

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

INTERNATIONAL PAPER CO /NEW/ reported fourth quarter 2022 results: net income $(318) million, EPS $(0.90) per diluted share.

Period: fourth quarter 2022
Net income: $(318) million
EPS: $(0.90) per diluted share
Result: reported results

Exact text from the filing

Fourth quarter net earnings (loss) attributable to International Paper of $(318) million ($(0.90) per diluted share)

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

INTERNATIONAL PAPER CO /NEW/ filing history →

Source: SEC EDGAR

accession 0000051434-23-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.